Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001654954-16-004346
Filing Date
2016-11-28
Accepted
2016-11-28 15:18:33
Documents
2

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT camberMYGN201613g.htm SC 13G 61908
2 JOINT FILING AGREEMENT MYGN13ga2016ex1filed.htm EX-1 4915
  Complete submission text file 0001654954-16-004346.txt   68309
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Subject) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G | Act: 34 | File No.: 005-48577 | Film No.: 162019694
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 101 HUNTINGTON AVENUE SUITE 2101 BOSTON MA 02199
Business Address 101 HUNTINGTON AVENUE SUITE 2101 BOSTON MA 02199 617-717-6600
Camber Capital Management LLC (Filed by) CIK: 0001444043 (see all company filings)

EIN.: 421693587 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G